How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- A nine-year-old boy went to a school bathroom in Brazil and what he found gave him the biggest scare of his life May 25, 2022
- “Work is being done to ensure that people with paraplegia can use exoskeletons in an agile way” Jul 6, 2021
- Irina Baeva in New York: “I have a smile from ear to ear” Sep 20, 2020
- Honduran prosecutor Karen Almendares was assassinated: it is the third crime of this type in Latin America in less than a month May 28, 2022
- The restrictions in Archena reactivate the internal battle in the regional PP Jul 15, 2021
- Kai Pflaume makes a touching declaration of love for his wife Dec 23, 2020
- Chiara Ferragni supports the LGBTQ + community Jun 30, 2021